Lupin
Company Snapshot
Founded: 1968
Entity Type: Public
Employees: 22,645
Region: India
Revenue: $2,374.5 Millions
Revenue Year: 2023
Headquarter: Mumbai, India
Key Geographics: U.S., India, Other Countries
Corporate Address: 3rd Floor, Kalpataru Inspire Off. Western Expressway Highway Santacruz (East) Mumbai 400 055 India Tel. +91-22-6640-2323 www.lupin.com
Company Overview
Headquartered in Mumbai, India, Lupin Ltd. manufactures and markets a wide range of quality, affordable generic and branded formulations and APIs in multiple markets worldwide. Lupin offers its products in over 100 countries. The company manufactures generic products in areas including anti-TB, diabetes, respiratory, cardiovascular, and ophthalmic. Lupin has 15 manufacturing facilities across India, the U.S., Brazil, and Mexico. The company has seven R&D locations across India, the U.S., the Netherlands, Brazil, and Mexico.
Financial Highlights (FY 2023)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Lupin In News
Company's Business Segments
- Pharmaceuticals : This segment consist of Group producing, developing and marketing pharmaceutical products globally.
- Others : This segment consist of business of providing diagnostics services and healthcare service in digital space.
Applications/End User Industries
- Healthcare
- Pharmaceutical
- Biologics
- Central Nervous System
- Oncology
- Pediatrics
- Dermatology
- Animal Health
- Respiratory Care
- Cardiovascular Health
BCC Research Beacon 